Use of oxygen-15-labeled molecular oxygen for oxygen delivery studies of blood and blood substitutes

Advances in Experimental Medicine and Biology

Volumn 454, Issue , 1998, Pages 643-652

  Goins, B ^a   Klipper, R ^a   Martin, C ^b   Jerabek, P A ^b   Khalvati, S ^b   Fox, P T ^b   Cliff, R O ^c   Kwasiborski, V ^c   Rudolph, A S ^c   Phillips, W T ^a  

^a Department of Radiology ^*  (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NAVAL RESEARCH LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE;

ANIMAL CELL; ANIMAL TISSUE; BLEEDING; BLOOD SUBSTITUTION; BLOOD TRANSFUSION; CONFERENCE PAPER; EXCHANGE BLOOD TRANSFUSION; HEMOGLOBIN ANALYSIS; HUMAN; ISOTOPE LABELING; MALE; MOLECULAR DYNAMICS; NONHUMAN; OXYGEN TISSUE LEVEL; OXYGEN TRANSPORT; OXYGENATION; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0032414453     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-4863-8_76     Document Type: Conference Paper

References (13)

1. Winslow RM. Blood substitutes. Science & Medicine 1997;4:54-63.
2. Rudolph AS. Liposome encapsulated hemoglobin. In: Winslow RM, Vandergriff KD, Intagiletta M, ed. Blood Substitutes: Physiological Basis of Efficacy. Boston: Birkhauser, 1995: 90-104.
3. 2 in tissues. In: Hogan MC, Mathieu-Costello O, Poole DC, Wagner PD, ed. Oxygen Transport to Tissue XVI. New York: Plenum, 1994: 371-374.
4. 15O]oxygen, water and carbon monoxide. Appl Radiat Isot 1990;41:1173-1175.
5. Cherry SE, Phelps ME. Positron emission tomography: Methods and instrumentation. In: Sandler MP, Coleman RE, Wackers FJT, Patton JA, Gottschalk A, Hoffer PB, ed. Diagnostic Nuclear Medicine. Baltimore MD: Williams & Wilkins, 1996: 139-159. vol 1).
6. Hoffman JM, Hanson MW, Coleman RE. Clinical positron emission tomography imaging. Radiologic Clinics of North America 1993;31:935-959.
7. Raichle ME. Visualizing the mind. Scientific American 1994;270(4):58-64.
8. Ter-Pogossian MM, Eichling JO, Davis DO, Welch MJ. The measure in vivo of regional cerebral oxygen utilization by means of oxyhemoglobin labeled with radioactive oxygen-15. J Clin Invest 1970;49:381-391.
9. Phillips WT, Lemen L, Goins B, et al. Use of oxygen-15 to measure oxygen-carrying capacity of blood substitutes in vivo. American Journal of Physiology 1997;272:H2492-H2499.
10. Tomita S, Enoki Y, Yoshida H, Yasumitsu Y. A simple spectrophotometric method for determination of methemoglobin in dilute solutions. J Nara Med Assoc 1968;19:1-41.
11. Vandegriff KD, Winslow RM. The theoretical analysis of oxygen transport: A new strategy for the design of hemoglobin-based red cell substitutes. In: Winslow RM, Vandegriff KD, Intaglietta M, ed. Blood Substitutes: Physiological Basis of Efficacy. Boston: Birkhauser, 1995: 143-154.
12. Meyer GJ, Waters SL, Coenen HH, Luxen A, Maziere B, Langstrom B. PET radiopharmaceuticals in Europe: Current use and data relevant for the formulation of summaries of product characteristics. Eur J Nucl Med 1995;22:1420-1432.
13. Ghosh PR. The international state of PET. J Nucl Med 1991;32:28N-51N.